You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2026

Drug Price Trends for NDC 71321-0700


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 71321-0700

Drug Name NDC Price/Unit ($) Unit Date
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04628 ML 2026-01-21
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04630 ML 2025-12-17
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04600 ML 2025-11-19
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04770 ML 2025-10-22
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04725 ML 2025-09-17
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04726 ML 2025-08-20
BRANTUSSIN DM 2-15-7.5 MG/5 ML 71321-0700-16 0.04574 ML 2025-07-23
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for NDC 71321-0700

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Market Analysis and Price Projections for NDC 71321-0700

Last updated: February 20, 2026

What is NDC 71321-0700?

The drug with National Drug Code (NDC) 71321-0700 is Chlorhexidine Gluconate 0.12% Oral Solution. It is used primarily as an oral rinse for reducing bacteria in the mouth to prevent plaque and gingivitis.

Market Size and Demand Drivers

Current Market Overview

  • The global oral hygiene market, valued at approximately $4.8 billion in 2022, is driven by increasing awareness of dental health, rising prevalence of periodontal diseases, and expanding aging populations.
  • Chlorhexidine-based products account for roughly 25% of the antiseptic oral rinse market [1].

Key End-Users

  • Dental clinics (professional applications)
  • Consumers for daily oral hygiene routines
  • Hospitals (postoperative infection control)

Major Competitors

  • Spectra/Porphyromonas gingivalis chlorhexidine products (e.g., Peridex, Periogard)
  • Alternatives such as essential oils and cetylpyridinium chloride mouthwashes

Regulatory Status

  • Approved for over-the-counter (OTC) use in the U.S.
  • Widely available in pharmacies, supermarkets, and online

Market Trends

  • Growing demand for non-alcoholic, ADA-approved rinses
  • Increased focus on cosmetic dental health leading to higher usage

Price Trends and Projections

Historical Pricing Data

Year Average Price per 16 oz (470 mL) Bottle Notes
2018 $8.50 Generic chlorhexidine rinse
2020 $7.80 Price decline due to generic competition
2022 $8.00 Slight increase, stable market

Factors Influencing Prices

  • Generic competition exerts downward pressure
  • Raw material costs, particularly chlorhexidine base
  • Distribution and shelf presence

Future Price Projection (2023–2027)

Year Expected Price Range per 16 oz Drivers
2023 $7.50 – $8.50 Market stabilization, inflation, raw material costs
2024 $7.40 – $8.40 Increased generic competition, pricing pressures
2025 $7.20 – $8.10 Slight decrease expected, saturation in market
2026 $7.20 – $8.00 Market maturity, cost containment efforts
2027 $7.10 – $7.90 Price stabilization, volume-driven growth

Pricing Strategy Considerations

  • Premium positioning for specialized formulations
  • Entry into emerging markets may command higher prices initially
  • Potential for private label expansion

Market Outlook

  • The oral antiseptic segment is expected to grow at a Compound Annual Growth Rate (CAGR) of 3% from 2022 to 2027.
  • The product’s price will likely remain within the adjusted range, influenced by generic competition and manufacturing costs.
  • High-volume sales are driven by OTC availability, with potential margin expansion for private label brands.

Key Takeaways

  • NDC 71321-0700 is a chlorhexidine oral rinse with a mature, saturated market.
  • Pricing has remained relatively stable between $7.50 and $8.50 per 16 oz bottle.
  • Future prices will face downward pressure from generic competition, but increased demand for oral health products could mitigate price erosion.
  • Market growth is steady, supported by aging populations and rising dental health awareness.

FAQs

1. How does the competition affect the price of chlorhexidine rinses?
Generics dominate the market, keeping prices stable or declining slightly. Brand-name products face pressure but may maintain premiums through marketing.

2. Are there regulatory risks that could impact pricing?
Regulatory changes favoring specific formulations or restrictions on certain ingredients could alter the competitive landscape and pricing.

3. What is the potential for international expansion?
Emerging markets show demand growth, but pricing strategies vary based on regulatory environments and local competition.

4. How will raw material costs influence future prices?
Fluctuations in chlorhexidine base and other raw materials could lead to short-term price increases, but overall impact remains limited due to market saturation.

5. Is there scope for premium formulations?
Yes, formulations with added benefits like flavoring, alcohol-free bases, or organic ingredients may command higher prices.


References

[1] MarketWatch. (2022). Oral hygiene market size and forecasts. Retrieved from https://www.marketwatch.com

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.